It is morally wrong to make a mother choose between treatment for herself and treatment for her newborn. It is morally wrong that people should be dying of AIDS when treatment is available.
It is morally wrong that babies are still being born with HIV when we know how to prevent it. It is morally wrong that children are still growing up as AIDS orphans.
To be a partner for women and girls against violence and injustice, you do not have to be experts on human rights or gender. You do have to be committed to always asking in your daily work: 'How can I better engage women and girls to understand what they need'
A society that cuts itself off from its youth severs its lifeline; it is condemned to bleed to death.
When the history of our times is written, will we be remembered as the generation that turned our backs in a moment of global crisis or will it be recorded that we did the right thing?
No disease group is as vast and complex in scope as the noncommunicable diseases (NCDs). Incorporating social determinants such as income and education, the NCDs call for an equally massive and comprehensive response
There are 1.2 billion adolescents across the world, 9 out of 10 of these young people live in developing countries. Millions are denied their basic rights to quality education, health care, protection and exposed to abuse and exploitation.
Of all the forms of inequality, injustice in health care is the most shocking and inhumane.
“The early years in a child’s life—when the human brain is forming—represent a critically important window of opportunity to develop a child’s full potential and shape key academic, social, and cognitive skills that determine a child’s success in school and in life.”—President Barack Obama
“If art is to nourish the roots of our culture, society must set the artist free to follow his vision wherever it takes him.”—President JF Kennedy
"The true character of a society is revealed in how it treats its children. History will judge us by the difference we make in the everyday lives of children."—President Nelson Mandela

Editorial Policies

Focus and Scope

The International Journal of MCH and AIDS (IJMA) is a multidisciplinary, global health, open access journal. IJMA welcomes manuscripts on all areas of global maternal and child health, public health, health issues of men, women, families, and the science, practice, and policy of HIV/AIDS.

IJMA focuses on the social determinants of health and disease as well as on the disparities in the burden of communicable, non-communicable, and neglected tropical diseases affecting infants, children, women, adults, and families across the life span around the world.

IJMA is the only peer-reviewed journal in the world devoted exclusively to the study of MCH and HIV/AIDS.

Mission

Disseminate sound research, ensuring widest dissemination and maximum impact.

Vision

To become the leading and authoritative source/voice for the dissemination of high-quality research and policy analyses by global health researchers on new and emerging issues about maternal, neonatal, and child health and HIV/AIDS in the developing world, and foster a stimulating North-South dialogue in health disparities research, policy, and programming.

IJMA covers, but is not limited to, the following global health subject areas and topics:

  • Life expectancy, cause-specific mortality, and human development;
  • Maternal, infant, child, and youth mortality and morbidity in developing countries;
  • Determinants and consequences of childhood and adolescent obesity and sedentary behaviors, including smoking, alcohol;
  • Substance use, violence and injury;
  • Quality of life and mental health disparities affecting MCH and HIV/AIDS populations;
  • Social, behavioral, and biological determinants of MCH and HIV/AIDS and well-being;
  • Disparities in health and well-being based on gender, race, ethnicity, immigrant status, social class, education, income disability status, etc.;
  • Region and/or country specific studies;
  • Family health, including changing dynamics of modern families;
  • Human sexuality and human development;
  • Neglected tropical diseases;
  • Use of science, technology and innovation to address national and global health issues;
  • Technological innovations to address family health, MCH and HIV/AIDS;
  • Cross-national research on MCH and HIV/AIDS issues across the world;
  • Issues of resilience among populations impacted by HIV/AIDS;
  • Linkages between research results and national public policy formulation process.

 

Section Policies

Original Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Methodology Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Brief Research Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Reports

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Field Studies

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Editorial

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Commentary

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Systematic Review

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Letters to the Editor

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Book Review

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Short Report /Communication

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Conference Report

Checked Open Submissions Checked Indexed Checked Peer Reviewed

WAME Statement

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

All manuscripts submitted to IJMA will be subjected to peer-review and are therefore expected to be of high quality.

Manuscripts submitted for publication consideration must have the ability to make a contribution to the field of global health. This contribution may be small but meaningful and forms the rubric of what our reviewers and editors look for during the review process. Prior to submitting their manuscripts, prospective authors are encouraged to always ask themselves: what is the small contribution that my manuscript contributes to the field? This contribution could be in research, practice, policy or otherwise.

IJMA applies a very rigorous review process in determining which articles are accepted and eventually published. IJMA Editors understand the value of rapid dissemination of knowledge; however, the journal will not compromise rigor of its review policy for expediency of publication. We strive for a rapid review and subsequent publication of high-quality manuscripts. 

Manuscript Review Process

Below is a summary of IJMA’s 5-step manuscript review and editorial process:

  1. An author submits a manuscript
  2. The manuscript is assigned to an IJMA Editor or Editor-in-Chief
  3. The assigned IJMA Editor reviews the manuscript and makes an initial decision based on the quality of the manuscript and editorial priorities. The assigned editor will determine either to send the manuscript to peer-reviewers or reject the manuscript at that point.
  4. For the manuscripts that are sent for peer reviewer, the Editor makes a decision based on editorial priorities, manuscript quality, reviewer recommendations, and perhaps discussion with fellow editors. At this point, the decision is usually to request a revised manuscript, reject the manuscript, or provisionally accept the manuscript.
  5. The decision letter is sent to the author informing him/her of the decision in the above step.

Single Blind Review

Submitted manuscripts are usually reviewed by at least two expert peer-reviewers. Peer reviewers recommend to the Editori-in-Chief (EIC) whether a manuscript should be accepted, revised or rejected. They also alert the EIC of any issues relating to author misconduct such as plagiarism and unethical behavior.

IJMA operates a single blind review system. This means that the names of the reviewers are hidden from the author. With this type of peer-review, reviewer anonymity allows for impartial decisions free from influence by the author.

Double Blind Reviews

IJMA Editors and Editorial Board members set the research agenda for the journal. Therefore, IJMA Editors and Editorial Board members regularly publish their work in the journal. To address the potential conflict arising from editors making decisions on their own manuscripts, IJMA employs the doube-blind review in the review of manuscripts authored by its Editors and Editorial Board members. 

To be published in the journal, a manuscript must receive favorable review from at least two peer-reviewers. If a manuscript receives an even review by two reviewers, the Editor-in-Chief, Editor, or a senior member of the editorial board will make the final recommendation upon review of the manuscript. Reviewers submit their reports on the manuscripts along with their recommendation of one of the following actions:

  1. Publish manuscript unaltered (this is usually very rare)
  2. Consider publishing manuscript after minor changes
  3. Consider publishing manuscript after major changes
  4. Reject manuscript

After receiving and reviewing comments from all the external reviewers, the Editor-in-Chief makes the final decision, which may be one of the following:

  1. Publish manuscript unaltered
  2. Consider publishing manuscript after minor changes
  3. Consider publishing manuscript after major changes
  4. Reject manuscript

If the Editor-in-Chief recommends “Publish Unaltered,” the manuscript is accepted for publication.

If the Editor-in-Chief recommends, “Consider publishing after minor changes,” the authors are notified to prepare and submit a final copy of their manuscript with the required minor changes suggested by the peer-reviewers.

The Editor-in-Chief only reviews the revised manuscript after the minor changes have been made by the authors. Once the Editor-in-Chief is satisfied with the final manuscript, the manuscript will be accepted for publication.

If the Peer-Reviewers recommend, “Consider after Major Changes,” and the author is from a developing country, the recommendation is communicated to the authors and the authors will be recommended for the IJMA Peer Mentoring Program (IPMP).  Authors of manuscripts recommended to IPMP reserve the right to participate in the program or withdraw their manuscripts at this stage. Authors will have to resubmit their manuscripts to the journal’s peer-review system after participating in the IPMP.

Click here to read more about our IPMP for authors from developing countries.

 

 

Publication Frequency

IJMA publishes one volume and two issues per calendar year. The journal operates a continuous publication model whereby accepted papers are published on a rolling basis, and published papers are serialized into two isues in one volume. Special Issues or journal suplements are included under the respective volume and issue in which they are published. 

 

Open Access Policy

The International Journal of MCH and AIDS (IJMA) is an open-access (OA) journal. Open access publishing is the practice of providing unrestricted access via the internet to peer-reviewed scholarly journal articles. Open access publishing is a new model for publishing scholarly journals. It provides immediate, worldwide, barrier-free access to the full-text of all published articles. For readers in developing world as well as those in developed countries, open access allows all interested readers to view, download, print, and redistribute any article without a subscription, enabling far greater distribution of an author’s work than the traditional subscription-based publishing model. 

According to Wikipedia, the number of articles published using the OA model has increased from 19,500 articles published in 2000 to about 191, 850 articles in 2009. It is not surprising that many authors in a variety of fields including public health now realize the benefits that open access publishing can provide in terms of increasing the impact of their work. A number of leading research institutions in the world including the U.S. National Institutes of Health, the U.K. Medical Research Council, etc., have begun to encourage their researchers to publish in open-access journals.

Unrestricted and Unlimited Access

IJMA and the editorial board believe that the scientific community and the general public can unlimitedly and immediately access all content published in our journals for free as soon as it is published on the Internet. We believe that immediate, worldwide, barrier-free, open access to the full text of research articles is in the best interests of the scientific community.  This means that IJMA does not have any income from selling subscriptions to print or online versions of the journal. IJMA is published by a U.S-based non-profit organization: this means that the goal of the journal is not to make profit.

Open Access License-Creative Commons

IJMA applies the Creative Commons Attribution License (CCAL) to all works we publish. Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in IJMA, so long as the original authors and source are cited. We allow the reuse and remixing of contents of the journal following the CC BY CC license.

For more information about CCAL, and to read the human-readable summary or the full license legal code, please click here.

 
 

Article Processing Charges/Contributions

In an OA publishing model, the costs of publication of an article are borne by an author. Some of these are paid from the authors funding or by their organization in the form of Article Processing Charges (APCs). The APCs replace subscription charges in the traditional publishing and allow publishers to make the full-text of every published article freely available to all interested readers. In addition, as an open-access journal, authors who publish in IJMA retain the copyright of their work, which is released under a “Creative Commons Attribution License,” enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.

To defray its editorial and production costs, IJMA must collect modest APCs from authors’ institutes or research funding bodies. Moreover, as a non-profit-publisher, our goal is to keep our open access publication charges at a minimum level just enough to defray the cost of production and maintenance of our servers and equipment. The APCs includes costs for professional copyediting, immediate publication upon acceptance, and different formats of publication (PDF editions).

IJMA’s APCs are place-based depending on the location of the authors. Our APCs enable us to support the journal and sustain a free-submission journal. Currently, our article processing charges for standard 7 or 8 paged published papers are as follows:

Developed (Tier 1) Countries: USD $500

Developing & Emerging (Tier 2) Countries: USD $300.

APCs Waivers and Discounts

We appreciate that some authors do not have access to funding to cover publication costs. The journal will will work with authors and arrange for part-payment when necessary.    

IJMA offers discounts on its article processing charges for regular submissions. The journal also publishes, without charge, selected articles invited by the Editors. In addition, we offer discounts to reviewers for the journal to thank them for their services or to previous authors to thank them for their loyalty. In recognition of reviewers’ support, any reviewer that returns a full review, on time, may receive a 25% discount on article processing charges for a paper for which they are the corresponding author, if submitted within 12 months of completing the review.

Options to Pay APCs

Following peer review, once a manuscript has received editorial acceptance, the article-processing charge becomes payable. Authors will receive a link to make payment for APCs through a secure link. IJMA accepts payment with major credit cards through one of our third-party payment processing services:

Click here to pay using PAYPAL,

Click here to pay using 2CHECKOUT, and

Click here to pay using DWOLLA. 

To ensure the security of your personal information, when you click on the Donate button below, you will be taken to a secure form on a secure server hosted by our payment providers — PayPal, 2Checkout, or Dwolla.  Upon request, alternative methods of payment will be provided to authors from countries were any of the payment processing services are not a

DONATIONS AND SUPPORT TO IJMA

IJMA’s publisher, the Global Health and Education Projects (GHEP), depends on your donations to carry out its work and activities throughout the United States (US) and across the world.  Please support the mission of the journal by making a donation.

Tax-Deductible Donations.  GHEP is a 501 (c) (3) tax-exempt non-profit organization recognized as a public charity by the U.S. Internal Revenue Service.  Our federal Employer Identification Number is: 45-2977882.  Your donations are tax-deductible to the fullest extent of the law. You’ll get a receipt for your donation which you will need in filing your tax.

Please click here to make your tax-deductible donation.

We thank you so much for your kindness and donation.

 

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

Editorial Freedom

IJMA is a multidisciplinary, peer-reviewed, global health, open access journal that publishes original research articles, review articles, clinical studies, evaluation studies, policy analyses, and commentaries/opinions in all areas of maternal, infant, child health, (MCH) and HIV/AIDS in low and middle-income countries, and in populations that are experiencing health disparities (i.e. inequalities) around the world.

IJMA adheres to the World Association of Medical Editors (WAME) Policy on “The Relationship between Journal Editors-in-Chief and Owners.” More specifically, the Editor-in-Chief has editorial independence and as such has full authority over the journal’s editorial content including how and when information is published. Editorial decisions are based solely on the validity of the work and its importance to readers, not on the policies or commercial interests of the publisher, if any.

IJMA is an official journal of the Global Health and Education Projects, Inc. (GHEP). GHEP is a US 501(c)(3) non-profit, non-partisan, non-religious, charitable, educational, research, and development organization dedicated to eliminating inequalities in health and education among local communities in the USA and worldwide.  GHEP addresses all aspects of educational and health inequalities affecting the most vulnerable individuals and populations in our communities, especially those that are historically known to experience inequalities in health and education outcomes, namely the poor, underserved, women, children, minorities, and new residents. GHEP does not interfere in the evaluation, selection or editing of individual articles, either directly or by creating environment where editorial decisions are strongly influenced.

 

Guidelines for Filing a Competing Interest Statement

Definition: Conflict of interest (COI) exists when there is a divergence between an individual’s private interests (competing interests) and his or her responsibilities to scientific and publishing activities such that a reasonable observer might perceive the individual’s behavior or judgment as motivated by considerations of the individual’s competing interests. COI in biomedical publishing affects everyone with a stake in research integrity including journals, research/academic institutions, funding agencies, the popular media, and members of the public.

Forms of COI: COI may exist in numerous forms including financial ties, academic commitments, personal relationships, political or religious beliefs, and institutional affiliations. In managing COI, IJMA abides to the policy statement of the World Association of Medical Editors (WAME). All authors will be required to declare their COI, if any, during the manuscript submission. Reviewers are asked to declare their COI after they accept to review a manuscript. Editors should also declare their COI during handling of a manuscript. IJMA shall publish these declarations, or lack thereof, in the final publication.

Management of COI:The management of COI depends on disclosure because it is not possible to routinely monitor or investigate whether competing interests are present. COI disclosed by authors will be reviewed by the editorial leadership and an appropriate action will be taken. As elucidated in our peer-review process, reviewers and Editors with COI will be excluded from the process of review of the manuscript that they present with COI. If competing interests surface from other sources after a manuscript is submitted or published, IJMA leadership will investigate allegations of COI and depending on their nature, appropriate actions will be taken. If a manuscript has been published and COI surfaces later, the journal will publish the results of the investigation as a correction to the article and ask the author(s) to explain, in a published letter, why the COI was not revealed earlier during the submission and review process.

 

Disposal of Material

Once published, all copies of the manuscript, correspondence and artwork will be held for at least one year before they are finally disposed.

 

International Editorial Board

IJMA’s editorial team comprises of a multi-disciplinary team of global health experts, representing 21 countries from all regions of the World Health Organization. Our board reflects a wide spectrum of the developed and developing countries. This means that each manuscript submitted to IJMA receives rigorous and fairest opportunity from experts who possess both subject-matter and geographic expertise in the subject area of the submission.

 

Advertisement

IJMA maintains unsurpassed advertisement exposure and competitive services. The weekly scheduled delivery of the electronic table of contents (eTOC) provides advertisers excellent outreach to our international audience.

  • Exciting Features
  • Low ad page rates and hyperlink service available.
  • Low priced banner ads.
  • Sponsorship of weekly eTOC alerts newsletter.
  • Unsurpassed International Exposure.
  • Classified ads.

To advertise and reach buyers with significant purchasing power, contact the Managing Editor at info@mchandaids.org.


x
Message